Literature DB >> 26029305

Renal cell carcinoma after neuroblastoma: A case study and review of the literature.

Brendan Wallace1, Michael Organ2, Scott Bagnell3, Ricardo Rendon4, Jennifer Merrimen4.   

Abstract

We present a case of renal cell carcinoma (RCC) arising in a 26-year-old patient with a history of neuroblastoma. RCC after a previous diagnosis of neuroblastoma is very uncommon, and there have only been 23 reported cases. Using the results of our patient workup, we hoped to determine whether there was a genetic predisposition or iatrogenic cause for the RCC. There is no clear explanation why neuroblastoma survivors are prone to developing RCC. However, genetic predisposition and previous treatment likely play a role. Since there have been few cases described, and few investigations into the genetics of this subtype of RCC, it remains important for individual cases to be added to the literature of this recently described and rare entity.

Entities:  

Year:  2015        PMID: 26029305      PMCID: PMC4439234          DOI: 10.5489/cuaj.2564

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  10 in total

1.  A young woman with multiple kidney lesions.

Authors:  Thomas W Flaig; Kimi L Kondo; Francisco G La Rosa; Brian Kavanagh; E David Crawford
Journal:  Oncology (Williston Park)       Date:  2010-03       Impact factor: 2.990

2.  Paraganglioma, neuroblastoma, and a SDHB mutation: Resolution of a 30-year-old mystery.

Authors:  R Neil Schimke; Debra L Collins; Catherine A Stolle
Journal:  Am J Med Genet A       Date:  2010-06       Impact factor: 2.802

3.  The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.

Authors:  John R Srigley; Brett Delahunt; John N Eble; Lars Egevad; Jonathan I Epstein; David Grignon; Ondrej Hes; Holger Moch; Rodolfo Montironi; Satish K Tickoo; Ming Zhou; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

4.  Long-term complications in survivors of advanced stage neuroblastoma.

Authors:  Caroline Laverdière; Nai-Kong V Cheung; Brian H Kushner; Kim Kramer; Shakeel Modak; Michael P LaQuaglia; Suzanne Wolden; Kirsten K Ness; James G Gurney; Charles A Sklar
Journal:  Pediatr Blood Cancer       Date:  2005-09       Impact factor: 3.167

5.  Rhabdomyosarcoma-associated renal cell carcinoma: a link with constitutional Tp53 mutation.

Authors:  Sarah Curry; Fadi Ibrahim; David Grehan; Michael McDermott; Michael Capra; David Betts; Maureen O'Sullivan
Journal:  Pediatr Dev Pathol       Date:  2010-11-05

6.  Long-term urological complications in survivors younger than 15 months of advanced stage abdominal neuroblastoma.

Authors:  M A Koyle; D A Hatch; P D Furness; M A Lovell; L F Odom; E A Kurzrock
Journal:  J Urol       Date:  2001-10       Impact factor: 7.450

Review 7.  Uncommon and recently described renal carcinomas.

Authors:  John R Srigley; Brett Delahunt
Journal:  Mod Pathol       Date:  2009-06       Impact factor: 7.842

Review 8.  Rapid development of metastatic Xp11 translocation renal cell carcinoma in a girl treated for neuroblastoma.

Authors:  Ryan C Hedgepeth; Ming Zhou; Jonathan Ross
Journal:  J Pediatr Hematol Oncol       Date:  2009-08       Impact factor: 1.289

Review 9.  Renal cell carcinoma in long-term survivors of advanced stage neuroblastoma in early childhood.

Authors:  Julie M Fleitz; Sandra L Wootton-Gorges; Josephine Wyatt-Ashmead; Loris McGavran; Martin Koyle; Daniel C West; Eric A Kurzrock; Kenneth W Martin; Lorrie F Odom
Journal:  Pediatr Radiol       Date:  2003-05-14

10.  Renal carcinoma after childhood cancer: a report from the childhood cancer survivor study.

Authors:  Carmen L Wilson; Kirsten K Ness; Joseph P Neglia; Sue Hammond; Margarett Shnorhavorian; Wendy L Leisenring; Marilyn Stovall; Leslie L Robison; Gregory T Armstrong
Journal:  J Natl Cancer Inst       Date:  2013-03-20       Impact factor: 13.506

  10 in total
  2 in total

1.  Secondary renal neoplasia following chemotherapy or radiation in pediatric patients.

Authors:  Sounak Gupta; Chad M Vanderbilt; Bradley C Leibovich; Loren Herrera-Hernandez; Aditya Raghunathan; William R Sukov; Jesse S Voss; Emily G Barr Fritcher; Katelyn A Reed; Christine M Lohse; Victor E Reuter; Rafael E Jimenez; R Houston Thompson; John C Cheville
Journal:  Hum Pathol       Date:  2020-07-15       Impact factor: 3.466

Review 2.  Late Effects and Survivorship Issues in Patients with Neuroblastoma.

Authors:  Danielle Novetsky Friedman; Tara O Henderson
Journal:  Children (Basel)       Date:  2018-08-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.